Abliva AB Stock: price and insider trades · Sweden

Abliva AB: what insiders have been doing

Insider filings for Abliva AB are scarce in the Finansinspektionen feed, the latest one published on 7 March 2025. This page will fill in as new trades are disclosed. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.

Thresholds

n/a

Buy Volume

n/a

Sell Volume

€23,549

1 ops. · all time

Who traded when

BuySale

Eskil Elmér1 sale

Financial data

· cache

Last declaration on 7 March 2025

Declarations1 total

▼

Eskil Elmér

Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives7 Mar 2025

258,740 SEK15FI-SE ↗

574,978 shares@ SEK 0.45100.0% of flowAktieSE0002575340FI:A003M247-1

1 of 1 declaration

About Abliva AB

Abliva AB is a Swedish biopharmaceutical company focused on developing treatments for mitochondrial diseases. It is listed on the Stockholm Stock Exchange (XSTO).